Who owns PROTARA THERAPEUTIC INC?
- Ticker: TARA
- CUSIP Number: 74365u107
Tip: Access positions for across all investors
Analyze quarterly positions in Protara Therapeutic with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Protara Therapeutic stock
Who bought or sold PROTARA THERAPEUTIC INC this quarter?
Fund or Company Name |
Shares Held |
Valued At |
Change in Shares |
As Of |
Actions |
|---|---|---|---|---|---|
| RA Capital Management | 3.4M | $18M | 79% | Dec 2024 |
|
| Henderson Group | 2.3M | $12M | 100% | Dec 2024 |
|
| Adage Capital Partners GP | 2.3M | $12M | 100% | Dec 2024 |
|
| Toronto-Dominion Bank | 2.1M | $11M | 100% | Dec 2024 |
|
| Opaleye Management | 1.8M | $9.6M | 9% | Dec 2024 |
|
| Blackstone Group | 1.7M | $8.9M | 100% | Dec 2024 |
|
| Velan Capital Investment Management | 1.6M | $8.3M | 175% | Dec 2024 |
|
| Sio Capital Management | 1.4M | $7.6M | 100% | Dec 2024 |
|
| Integral Health Asset Management | 1.4M | $7.4M | 100% | Dec 2024 |
|
| Vanguard Group | 1.4M | $7.2M | 79% | Dec 2024 |
|
| Citadel Advisors | 1.1M | $5.7M | 57% | Dec 2024 |
|
| Woodline Partners | 853k | $4.5M | 0% | Dec 2024 |
|
| 5AM Venture Management | 800k | $4.2M | 100% | Dec 2024 |
|
| Baker Bros. Advisors | 537k | $2.8M | 0% | Dec 2024 |
|
| Driehaus Capital Management | 517k | $2.7M | 100% | Dec 2024 |
|
| Susquehanna International | 376k | $2.0M | 100% | Dec 2024 |
|
| Millennium Management | 372k | $2.0M | 2479% | Dec 2024 |
|
| Superstring Capital Management | 360k | $1.9M | 100% | Dec 2024 |
|
| Ikarian Capital | 351k | $1.9M | 125% | Dec 2024 |
|
| Stempoint Capital | 332k | $1.8M | -65% | Dec 2024 |
|
| Walleye Trading Advisors | 221k | $1.2M | 100% | Dec 2024 |
|
| Goldman Sachs Group | 203k | $1.1M | 100% | Dec 2024 |
|
| Oppenheimer & Co | 201k | $1.1M | 12% | Dec 2024 |
|
| Bank of America Corporation | 194k | $1.0M | 53014% | Dec 2024 |
|
| Geode Capital Management | 180k | $948k | 6% | Dec 2024 |
|
| Bnp Paribas Arbitrage, Snc | 152k | $802k | 100% | Dec 2024 |
|
| UBS Group | 149k | $789k | 1914% | Dec 2024 |
|
| Renaissance Technologies | 142k | $751k | -58% | Dec 2024 |
|
| J. Goldman & Co | 142k | $748k | 100% | Dec 2024 |
|
| ADAR1 Capital Management | 123k | $648k | 100% | Dec 2024 |
|
| BlackRock | 116k | $613k | -1% | Dec 2024 |
|
| Morgan Stanley | 100k | $526k | 100% | Dec 2024 |
|
| Barclays | 93k | $492k | 100% | Dec 2024 |
|
| Boothbay Fund Management | 89k | $470k | 411% | Dec 2024 |
|
| State Street Corporation | 82k | $434k | 209% | Dec 2024 |
|
| 683 Capital Management | 62k | $330k | 100% | Dec 2024 |
|
| Jane Street | 54k | $287k | 100% | Dec 2024 |
|
| Branch Banking & Trust Company | 40k | $211k | 0% | Dec 2024 |
|
| Commonwealth Equity Services | 37k | $195k | 90% | Dec 2024 |
|
| LPL Financial | 36k | $190k | -22% | Dec 2024 |
|
| GSA Capital Partners | 36k | $188k | 100% | Dec 2024 |
|
| Bailard | 30k | $157k | 100% | Dec 2024 |
|
| Northern Trust | 29k | $152k | -1% | Dec 2024 |
|
| Bridgeway Capital Management | 25k | $132k | -49% | Dec 2024 |
|
| Dimensional Fund Advisors | 21k | $111k | 100% | Dec 2024 |
|
| Squarepoint Ops | 21k | $110k | 100% | Dec 2024 |
|
| HBK Investments | 20k | $106k | 100% | Dec 2024 |
|
| Bank of New York Mellon | 16k | $84k | -11% | Dec 2024 |
|
| Two Sigma Investments | 14k | $72k | -93% | Dec 2024 |
|
| Citigroup | 13k | $68k | 100% | Dec 2024 |
|
| XTX Topco | 12k | $62k | -64% | Dec 2024 |
|
| Royal Bank of Canada | 3.5k | $18k | 0% | Dec 2024 |
|
| Group One Trading | 1.4k | $7.4k | 100% | Dec 2024 |
|
| Tower Research Capital | 117.00 | $618.005700 | -96% | Dec 2024 |
|
| SBI Securities | 103.00 | $544.004800 | 100% | Dec 2024 |
|
Who sold out of Protara Therapeutic?
Fund or Company Name |
Date Sold |
Shares Held |
Valued At |
|---|---|---|---|
| Boxer Capital | Sep 2024 | 812k | $1.5M |
| Two Sigma Advisers | Sep 2024 | 152k | $278k |
| Marshall Wace | Sep 2024 | 77k | $142k |
| CIBC World Markets | Sep 2024 | 28k | $51k |
| Simplex Trading | Sep 2024 | 373.00 | $0 |